Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure

Philadelphia‐negative (Ph(−)) myeloproliferative neoplasms (MPN) do rarely transform to acute lymphoblastic leukemia (ALL). While causality is difficult to establish, a few cases of ALL arising after exposure to lenalidomide for registered indications (multiple myeloma, myelodysplastic syndrome with...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhuraiji, Ahmad, Naqvi, Kiran, Huh, Yang O., Ho, Coty, Verstovsek, Srdan, Bose, Prithviraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771935/
https://www.ncbi.nlm.nih.gov/pubmed/29375856
http://dx.doi.org/10.1002/ccr3.1264
_version_ 1783293326780268544
author Alhuraiji, Ahmad
Naqvi, Kiran
Huh, Yang O.
Ho, Coty
Verstovsek, Srdan
Bose, Prithviraj
author_facet Alhuraiji, Ahmad
Naqvi, Kiran
Huh, Yang O.
Ho, Coty
Verstovsek, Srdan
Bose, Prithviraj
author_sort Alhuraiji, Ahmad
collection PubMed
description Philadelphia‐negative (Ph(−)) myeloproliferative neoplasms (MPN) do rarely transform to acute lymphoblastic leukemia (ALL). While causality is difficult to establish, a few cases of ALL arising after exposure to lenalidomide for registered indications (multiple myeloma, myelodysplastic syndrome with 5q deletion) have been described in the literature.
format Online
Article
Text
id pubmed-5771935
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57719352018-01-26 Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure Alhuraiji, Ahmad Naqvi, Kiran Huh, Yang O. Ho, Coty Verstovsek, Srdan Bose, Prithviraj Clin Case Rep Case Reports Philadelphia‐negative (Ph(−)) myeloproliferative neoplasms (MPN) do rarely transform to acute lymphoblastic leukemia (ALL). While causality is difficult to establish, a few cases of ALL arising after exposure to lenalidomide for registered indications (multiple myeloma, myelodysplastic syndrome with 5q deletion) have been described in the literature. John Wiley and Sons Inc. 2017-12-06 /pmc/articles/PMC5771935/ /pubmed/29375856 http://dx.doi.org/10.1002/ccr3.1264 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Alhuraiji, Ahmad
Naqvi, Kiran
Huh, Yang O.
Ho, Coty
Verstovsek, Srdan
Bose, Prithviraj
Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
title Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
title_full Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
title_fullStr Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
title_full_unstemmed Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
title_short Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
title_sort acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771935/
https://www.ncbi.nlm.nih.gov/pubmed/29375856
http://dx.doi.org/10.1002/ccr3.1264
work_keys_str_mv AT alhuraijiahmad acutelymphoblasticleukemiasecondarytomyeloproliferativeneoplasmsorafterlenalidomideexposure
AT naqvikiran acutelymphoblasticleukemiasecondarytomyeloproliferativeneoplasmsorafterlenalidomideexposure
AT huhyango acutelymphoblasticleukemiasecondarytomyeloproliferativeneoplasmsorafterlenalidomideexposure
AT hocoty acutelymphoblasticleukemiasecondarytomyeloproliferativeneoplasmsorafterlenalidomideexposure
AT verstovseksrdan acutelymphoblasticleukemiasecondarytomyeloproliferativeneoplasmsorafterlenalidomideexposure
AT boseprithviraj acutelymphoblasticleukemiasecondarytomyeloproliferativeneoplasmsorafterlenalidomideexposure

Ejemplares similares